|
Tabla 3: Puntuación Gastrointestinal Symptom Rating Scale significativo de acuerdo a variables categorizadas. |
||
|
Síntoma |
Puntuación |
p |
|
Dolor de apetito |
||
|
Tiempo postrasplante (meses) |
||
|
< 27 |
3.5 ± 1.80 |
|
|
> 27 |
2.49 ± 1.60 |
0.004* |
|
Régimen de inmunosupresión |
||
|
Tacrolimus |
3.5 ± 1.80 |
|
|
Sirolimus |
2.6 ± 1.60 |
|
|
Ciclosporina |
1.9 ± 1.25 |
0.006‡ |
|
Dosis de micofenolato (mg/día) |
||
|
< 1,000 |
2.54 ± 1.70 |
|
|
> 1,000 |
3.29 ± 1.80 |
0.038§ |
|
Borborigmos |
||
|
Presión diastólica (mmHg) |
||
|
< 80 |
2.2 ± 1.70 |
|
|
> 80 |
1.5 ± 0.90 |
0.061 |
|
Distensión abdominal |
||
|
Sexo |
||
|
Femenino |
2.6 ± 2.00 |
|
|
Masculino |
1.4 ± 1.00 |
0.002* |
|
Régimen de inmunosupresión |
||
|
Tacrolimus |
2.26 ± 1.80 |
|
|
Sirolimus |
1.55 ± 1.40 |
|
|
Ciclosporina |
1.08 ± 0.20 |
0.027‡ |
|
Constipación |
||
|
Peso (kg) |
||
|
< 64.5 |
2 ± 1.50 |
|
|
> 64.5 |
1.2 ± 1.00 |
0.007§ |
|
Hemoglobina (mg/dL) |
||
|
< 12.7 |
2.35 ± 1.75 |
|
|
> 12.7 |
1.38 ± 1.07 |
0.005§ |
|
Sexo |
||
|
Femenino |
2.3 ± 1.70 |
|
|
Masculino |
1.3 ± 0.90 |
0.001* |
|
Diarrea |
||
|
Hemoglobina (mg/dL) |
||
|
< 12.7 |
1.46 ± 0.90 |
|
|
> 12.7 |
1.13 ± 0.50 |
0.006§ |
|
Sexo |
||
|
Femenino |
1.45 ± 0.90 |
|
|
Masculino |
1.14 ± 0.52 |
0.045* |
|
* t de Student, ‡ ANOVA, § Mann-Whitney. |
||